These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31517072)

  • 1. Stereotactic body radiation therapy is associated with improved overall survival compared to chemoradiation or radioembolization in the treatment of unresectable intrahepatic cholangiocarcinoma.
    Sebastian NT; Tan Y; Miller ED; Williams TM; Alexandra Diaz D
    Clin Transl Radiat Oncol; 2019 Nov; 19():66-71. PubMed ID: 31517072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Impacting Survival After Transarterial Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: A Combined Analysis of the Prospective CIRT Studies.
    Reimer P; Vilgrain V; Arnold D; Balli T; Golfieri R; Loffroy R; Mosconi C; Ronot M; Sengel C; Schaefer N; Maleux G; Munneke G; Peynircioglu B; Sangro B; Kaufmann N; Urdaniz M; Pereira H; de Jong N; Helmberger T
    Cardiovasc Intervent Radiol; 2024 Mar; 47(3):310-324. PubMed ID: 38321223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting outcomes of Yttrium-90 radioembolization in heavily pretreated patients with intrahepatic cholangiocarcinoma.
    Zhao K; Erinjeri JP; Sotirchos VS; Alexander ES; Moussa AM; Marinelli B; Ziv E; Sofocleous CT; Abou-Alfa GK; Jarnagin WR; Karimi A; Yarmohammadi H
    Abdom Radiol (NY); 2023 Jul; 48(7):2434-2442. PubMed ID: 37145313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformal external beam radiation or selective internal radiation therapy-a comparison of treatment outcomes for hepatocellular carcinoma.
    Oladeru OT; Miccio JA; Yang J; Xue Y; Ryu S; Stessin AM
    J Gastrointest Oncol; 2016 Jun; 7(3):433-40. PubMed ID: 27284477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional Therapy for Intrahepatic Cholangiocarcinoma.
    Owen M; Makary MS; Beal EW
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization.
    Hardy-Abeloos C; Lazarev S; Ru M; Kim E; Fischman A; Moshier E; Rosenzweig K; Buckstein M
    Int J Radiat Oncol Biol Phys; 2019 Dec; 105(5):968-976. PubMed ID: 31536781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and Safety after 103 Radioembolizations with Yttrium-90 Resin Microspheres in 73 Patients with Unresectable Intrahepatic Cholangiocarcinoma-An Evaluation of Predictors.
    Paprottka KJ; Galiè F; Ingrisch M; Geith T; Ilhan H; Todica A; Michl M; Nadjiri J; Paprottka PM
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Socioeconomic and Survival Analysis of Radioembolization in Patients with Intrahepatic Cholangiocarcinoma: A Propensity Score-Adjusted Study.
    Wu X; Heller M; Lokken RP; Fidelman N; Lam A
    J Vasc Interv Radiol; 2023 May; 34(5):815-823.e1. PubMed ID: 36693521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant Yttrium-90 Transarterial Radioembolization with Resin Microspheres Prescribed Using the Medical Internal Radiation Dose Model for Intrahepatic Cholangiocarcinoma.
    Sarwar A; Ali A; Ljuboja D; Weinstein JL; Shenoy-Bhangle AS; Nasser IA; Morrow MK; Faintuch S; Curry MP; Bullock AJ; Ahmed M
    J Vasc Interv Radiol; 2021 Nov; 32(11):1560-1568. PubMed ID: 34454031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actual over 3-year survival after stereotactic body radiation therapy in patients with unresectable intrahepatic cholangiocarcinoma.
    Zhang XX; Ma HB; Li TH; Huang B; Jia NY; Meng Y
    Clin Transl Oncol; 2023 Mar; 25(3):731-738. PubMed ID: 36401766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Modality Radiation With External Beam Radiation Therapy and Transarterial Radioembolization for Hepatocellular Carcinoma With Gross Vascular Invasion.
    McGee HM; King MJ; Özbek U; Olson A; Kim E; Fischman AM; Schwartz M; Rosenzweig KE; Buckstein M
    Am J Clin Oncol; 2019 Apr; 42(4):367-374. PubMed ID: 30724782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of the Bologna Experience in Radioembolization of Intrahepatic cholangiocarcinoma.
    Mosconi C; Cacioppa LM; Cappelli A; Gramenzi AG; Vara G; Modestino F; Renzulli M; Golfieri R
    Technol Cancer Res Treat; 2023; 22():15330338231155690. PubMed ID: 36927302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Any role for transarterial radioembolization in unresectable intrahepatic cholangiocarcinoma in the era of advanced systemic therapies?
    Elvevi A; Laffusa A; Elisei F; Morzenti S; Guerra L; Rovere A; Invernizzi P; Massironi S
    World J Hepatol; 2023 Dec; 15(12):1284-1293. PubMed ID: 38223418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients.
    Teyateeti A; Mahvash A; Long JP; Abdelsalam ME; Avritscher R; Chasen B; Kaseb AO; Kuban JD; Murthy R; Odisio BC; Teyateeti A; Macapinlac HA; Kappadath SC
    J Hepatocell Carcinoma; 2020; 7():117-131. PubMed ID: 32984089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transarterial chemoembolization as an alternative to radioembolization is associated with earlier tumor recurrence than in radioembolization-eligible patients.
    Chung SW; Cho H; Shin H; Park J; Kim JY; Hong JH; Hur MH; Park MK; Lee YB; Yu SJ; Lee M; Kim YJ; Paeng JC; Yoon JH; Chung JW; Lee JH; Kim HC
    Front Oncol; 2023; 13():1081479. PubMed ID: 36925930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Holmium-166 Transarterial Radioembolization for the Treatment of Intrahepatic Cholangiocarcinoma: A Case Series.
    Vermeulen S; De Keukeleire K; Dorny N; Colle I; Van Den Bossche B; Nuttens V; Ooms D; De Bondt P; De Winter O
    Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Yttrium-90 Transarterial Radioembolization for Chemotherapy-Refractory Intrahepatic Cholangiocarcinoma: A Prospective, Observational Study.
    White J; Carolan-Rees G; Dale M; Patrick HE; See TC; Bell JK; Manas DM; Crellin A; Slevin NJ; Sharma RA
    J Vasc Interv Radiol; 2019 Aug; 30(8):1185-1192. PubMed ID: 31255499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiotherapy in intrahepatic cholangiocarcinoma: A systematic review.
    Bisello S; Camilletti AC; Bertini F; Buwenge M; Arcelli A; Macchia G; Deodato F; Cilla S; Mattiucci G; Autorino R; Brandi G; Strigari L; Cammelli S; Morganti AG
    Mol Clin Oncol; 2021 Aug; 15(2):152. PubMed ID: 34141431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Stereotactic Body Radiation Therapy and Radiofrequency Ablation in the Treatment of Intrahepatic Metastases.
    Jackson WC; Tao Y; Mendiratta-Lala M; Bazzi L; Wahl DR; Schipper MJ; Feng M; Cuneo KC; Lawrence TS; Owen D
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):950-958. PubMed ID: 29485074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of survival with stereotactic body radiation therapy following induction chemotherapy for unresected locally advanced pancreatic cancer.
    Ma SJ; Serra LM; Bartl AJ; Han HR; Fekrmandi F; Iovoli AJ; Prezzano KM; Hermann GM; Yu H; Singh AK
    J Radiother Pract; 2022 Sep; 21(3):403-410. PubMed ID: 36016862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.